申请人:Ajinomoto Co., Inc.
公开号:US08877805B2
公开(公告)日:2014-11-04
Compounds represented by formula (I):
wherein each symbol is as defined in the description, and pharmaceutically acceptable salts thereof are useful as hyperglycemic inhibitors having a serine protease inhibitory action and as prophylactic or therapeutic drugs for diabetes.
公式(I)所代表的化合物:其中每个符号如描述中所定义的,并且其药学上可接受的盐,可用作具有丝氨酸蛋白酶抑制作用的降糖剂,并且作为糖尿病的预防或治疗药物。